Equity Profile

PBH

Prestige Consumer Healthcare Inc.

Health CarePharmaceuticals$2.4B

Aug6Thu

Pre-Earnings Brief

UpcomingQ1-2027After Close5:00 PM EDT

Company Snapshot

Prestige Consumer Healthcare Inc. (PBH) is a healthcare company focused on over-the-counter pharmaceuticals and consumer health products....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a crucial measure of profitability, and investors will look for signs of growth or decline compared to previous quarters.

N/A

Revenue Growth

Revenue growth indicates how well the company is expanding its market presence and meeting consumer demand.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PBH Q1-2027 Earnings Preview

Context

Company Snapshot

Prestige Consumer Healthcare Inc. (PBH) is a healthcare company focused on over-the-counter pharmaceuticals and consumer health products. With a market cap of $2 billion, it plays a vital role in the health care sector, particularly as consumer spending on health products remains a key trend.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+0.03%

Avg Stock Reaction

+2.05%

Last Quarter Recap

In Q4-2026, Prestige Consumer Healthcare reported an EPS of $1.23, which was below the expected $1.39, resulting in an 11.7% surprise. The stock reacted positively, gaining 2.78% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Prestige Consumer Healthcare's upcoming earnings are mixed, given the recent performance and lack of analyst estimates. Investors are cautious after a series of earnings misses.

Bull Case

If the company can show improved EPS and revenue growth, it may indicate a turnaround and boost investor confidence.

Bear Case

Continued earnings misses or weak revenue could signal deeper issues within the company, leading to further stock declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to last quarter's $1.23?

EPS is a key indicator of profitability, and a significant improvement or decline could sway investor sentiment.

What is the revenue growth rate compared to previous quarters?

Revenue growth is essential for assessing the company's ability to expand and meet market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for a rebound in consumer health spending, which could positively impact Prestige's revenue.

Supporting Evidence

The options market is pricing a larger move than historical averages, indicating heightened expectations.

Recent trends in consumer health spending suggest a recovery that could benefit Prestige.

The company's historical EPS beat rate of 63% indicates potential for positive surprises.

Key Risk

If the company reports an EPS above $1.30, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core thesis revolves around whether Prestige can recover from recent earnings misses and demonstrate growth in both EPS and revenue.

Bull Confirmed If

An EPS increase to $1.30 or higher would confirm a positive outlook for the company.

Bear Confirmed If

An EPS below $1.20 would indicate ongoing struggles and could lead to a negative market reaction.

Pre-Earnings Positioning

Options Market

Implied Move

±12.18%

Historical Avg

±5.5%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±12.2% while PBH has averaged ±5.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

45.3%

Calls (0)P/C Ratio: 1.50Puts (10K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Prestige beats expectations, history suggests a potential stock increase of around +5.17%, confirming a positive turnaround.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty about future growth.

Miss

A miss could lead to a decline of around -3.16%, reinforcing concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any guidance on revenue growth expectations for the upcoming quarters.
2Details on new product launches or market expansions.
3Management's commentary on cost management and profitability strategies.
4Insights into consumer trends affecting sales of health products.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

Prestige Consumer Healthcare Inc. (PBH) is a healthcare company focused on over-the-counter pharmaceuticals and consumer health products....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a crucial measure of profitability, and investors will look for signs of growth or decline compared to previous quarters.

N/A

Revenue Growth

Revenue growth indicates how well the company is expanding its market presence and meeting consumer demand.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PBH Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+0.03%

Avg Stock Reaction

+2.05%

Last Quarter Recap

In Q4-2026, Prestige Consumer Healthcare reported an EPS of $1.23, which was below the expected $1.39, resulting in an 11.7% surprise. The stock reacted positively, gaining 2.78% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If the company can show improved EPS and revenue growth, it may indicate a turnaround and boost investor confidence.

Bear Case

Continued earnings misses or weak revenue could signal deeper issues within the company, leading to further stock declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to last quarter's $1.23?

EPS is a key indicator of profitability, and a significant improvement or decline could sway investor sentiment.

What is the revenue growth rate compared to previous quarters?

Revenue growth is essential for assessing the company's ability to expand and meet market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for a rebound in consumer health spending, which could positively impact Prestige's revenue.

Supporting Evidence

The options market is pricing a larger move than historical averages, indicating heightened expectations.

Recent trends in consumer health spending suggest a recovery that could benefit Prestige.

The company's historical EPS beat rate of 63% indicates potential for positive surprises.

Key Risk

If the company reports an EPS above $1.30, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core thesis revolves around whether Prestige can recover from recent earnings misses and demonstrate growth in both EPS and revenue.

Bull Confirmed If

An EPS increase to $1.30 or higher would confirm a positive outlook for the company.

Bear Confirmed If

An EPS below $1.20 would indicate ongoing struggles and could lead to a negative market reaction.

Pre-Earnings Positioning

Options Market

Implied Move

±12.18%

Historical Avg

±5.5%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±12.2% while PBH has averaged ±5.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

45.3%

Calls (0)P/C Ratio: 1.50Puts (10K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Prestige beats expectations, history suggests a potential stock increase of around +5.17%, confirming a positive turnaround.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty about future growth.

Miss

A miss could lead to a decline of around -3.16%, reinforcing concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any guidance on revenue growth expectations for the upcoming quarters.
2Details on new product launches or market expansions.
3Management's commentary on cost management and profitability strategies.
4Insights into consumer trends affecting sales of health products.